The rexinoid LG100268 and the synthetic triterpenoid...

Molecular Cancer Therapeutics 2008 / 05 Vol. 7; Iss. 5

The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis

Liby, K., Black, C. C., Royce, D. B., Williams, C. R., Risingsong, R., Yore, M. M., Liu, X., Honda, T., Gribble, G. W., Lamph, W. W., Sporn, T. A., Dmitrovsky, E., Sporn, M. B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-08-0023
Date:
May, 2008
File:
PDF, 496 KB
english, 2008
Conversion to is in progress
Conversion to is failed